Caricamento...
Development of New Antithrombotic Regimens for Patients with Acute Coronary Syndrome
Patients with acute coronary syndrome (ACS) require long-term antithrombotic intervention to reduce the risk of further ischemic events; dual antiplatelet therapy with a P2Y(12) inhibitor and acetylsalicylic acid (ASA) is the current standard of care. However, pivotal clinical trials report that pat...
Salvato in:
| Pubblicato in: | Clin Drug Investig |
|---|---|
| Autori principali: | , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Springer International Publishing
2019
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6555775/ https://ncbi.nlm.nih.gov/pubmed/30972665 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40261-019-00769-6 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|